OBJECTIVES: To conduct the first population size estimation and biological and behavioral surveillance survey among men who have sex with men (MSM) in Angola. DESIGN: Population size estimation with multiplier method and a cross-sectional study using respondent-driven sampling. SETTING: Luanda Province, Angola. Study was conducted in a large hospital. PARTICIPANTS: Seven hundred ninety-two self-identified MSM accepted a unique object for population size estimation. Three hundred fifty-one MSM were recruited with respondent-driven sampling for biological and behavioral surveillance survey. METHODS: Interviews and testing for HIV and syphilis were conducted on-site. Analysis used Respondent-Driven Sampling Analysis Tool and STATA 11.0. Univariate, bivariate, and multivariate analyses examined factors associated with HIV and unprotected sex. Six imputation strategies were used for missing data for those refusing to test for HIV. MAIN OUTCOME: A population size of 6236 MSM was estimated. Twenty-seven of 351 individuals were tested positive. Adjusted HIV prevalence was 3.7% (8.7% crude). With imputation, HIV seroprevalence was estimated between 3.8% [95% confidence interval (CI): 1.6 to 6.5] and 10.5% (95% CI: 5.6 to 15.3). Being older than 25 (odds ratio = 10.8, 95% CI: 3.5 to 32.8) and having suffered episodes of homophobia (odds ratio = 12.7, 95% CI: 3.2 to 49.6) significantly increased the chance of HIV seropositivity. CONCLUSIONS: Risk behaviors are widely reported, but HIV seroprevalence is lower than expected. The difference between crude and adjusted values was mostly due to treatment of missing values in Respondent-Driven Sampling Analysis Tool. Solutions are proposed in this article. Although concerns were raised about feasibility and adverse outcomes for MSM, the study was successfully and rapidly completed with no adverse effects.
OBJECTIVES: To conduct the first population size estimation and biological and behavioral surveillance survey among men who have sex with men (MSM) in Angola. DESIGN: Population size estimation with multiplier method and a cross-sectional study using respondent-driven sampling. SETTING: Luanda Province, Angola. Study was conducted in a large hospital. PARTICIPANTS: Seven hundred ninety-two self-identified MSM accepted a unique object for population size estimation. Three hundred fifty-one MSM were recruited with respondent-driven sampling for biological and behavioral surveillance survey. METHODS: Interviews and testing for HIV and syphilis were conducted on-site. Analysis used Respondent-Driven Sampling Analysis Tool and STATA 11.0. Univariate, bivariate, and multivariate analyses examined factors associated with HIV and unprotected sex. Six imputation strategies were used for missing data for those refusing to test for HIV. MAIN OUTCOME: A population size of 6236 MSM was estimated. Twenty-seven of 351 individuals were tested positive. Adjusted HIV prevalence was 3.7% (8.7% crude). With imputation, HIV seroprevalence was estimated between 3.8% [95% confidence interval (CI): 1.6 to 6.5] and 10.5% (95% CI: 5.6 to 15.3). Being older than 25 (odds ratio = 10.8, 95% CI: 3.5 to 32.8) and having suffered episodes of homophobia (odds ratio = 12.7, 95% CI: 3.2 to 49.6) significantly increased the chance of HIV seropositivity. CONCLUSIONS: Risk behaviors are widely reported, but HIV seroprevalence is lower than expected. The difference between crude and adjusted values was mostly due to treatment of missing values in Respondent-Driven Sampling Analysis Tool. Solutions are proposed in this article. Although concerns were raised about feasibility and adverse outcomes for MSM, the study was successfully and rapidly completed with no adverse effects.
Authors: Mohammed Dahoma; Lisa G Johnston; Abigail Holman; Leigh Ann Miller; Mahmoud Mussa; Asha Othman; Ahmed Khatib; Ramadhan Issa; Carl Kendall; Andrea A Kim Journal: AIDS Behav Date: 2011-01
Authors: Phoebe Kajubi; Moses R Kamya; H Fisher Raymond; Sanny Chen; George W Rutherford; Jeffrey S Mandel; Willi McFarland Journal: AIDS Behav Date: 2007-10-30
Authors: James Stannah; Elizabeth Dale; Jocelyn Elmes; Roisin Staunton; Chris Beyrer; Kate M Mitchell; Marie-Claude Boily Journal: Lancet HIV Date: 2019-10-07 Impact factor: 12.767
Authors: Roberta Z Horth; Beverly Cummings; Peter W Young; Joy Mirjahangir; Isabel Sathane; Rassul Nalá; Tim Lane; H Fisher Raymond Journal: AIDS Behav Date: 2015-11
Authors: Nikita Viswasam; Carrie E Lyons; Jack MacAllister; Greg Millett; Jennifer Sherwood; Amrita Rao; Stefan D Baral Journal: PLoS One Date: 2020-02-26 Impact factor: 3.240
Authors: P H Septime Hessou; Yolaine Glele-Ahanhanzo; Rheda Adekpedjou; Carin Ahouada; R Christian Johnson; Michel Boko; Hervé Tchala Vignon Zomahoun; Michel Alary Journal: BMC Public Health Date: 2019-12-04 Impact factor: 3.295
Authors: Michael E Herce; William M Miller; Agatha Bula; Jessie K Edwards; Pedro Sapalalo; Kathryn E Lancaster; Innocent Mofolo; Maria Lúcia M Furtado; Sharon S Weir Journal: J Int AIDS Soc Date: 2018-07 Impact factor: 5.396
Authors: Neema R Mosha; Omololu S Aluko; Jim Todd; Rhoderick Machekano; Taryn Young Journal: BMC Med Res Methodol Date: 2020-03-14 Impact factor: 4.615